Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris

Clinical and Experimental Dermatology

Volumn 29, Issue 6, 2004, Pages 658-663

  Teraki, Y ^a   Miyake, A ^a   Takebayashi, R ^a   Shiohara, T ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; HOMING RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 4;

ADULT; AGED; ARTICLE; BLOOD; CELL MIGRATION; CLINICAL ARTICLE; EPIDERMIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS VULGARIS; T LYMPHOCYTE;

ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOTAXIS, LEUKOCYTE; EPIDERMIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, CHEMOKINE; RECEPTORS, LYMPHOCYTE HOMING; T-LYMPHOCYTE SUBSETS;

EID: 9644289201     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01638.x     Document Type: Article

References (29)

1. Bos JD, De Rie MA. The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 1999; 20: 40-6.
2. Prinz JC. Which T cells cause psoriasis? Clin Exp Dermatol 1999; 24: 291-5.
3. Krueger JG, Wolfe JT, Nabeya RT et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 1995; 182: 2057-68.
4. Gottlieb SL, Gilleaudeau P, Johnson R et al. Response of psoriasis to a lymphocyte-selective toxin (DAB 389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995; 1: 442-7.
5. Ferenczi K, Burack L, Pope M et al. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vuigaris lesional skin: blood and skin comparisons by flow cytometry. J Autoimmun 2000; 14: 63-78.
6. + subsets. J Invest Dermatol 1998; 111: 1072-8.
7. Austin LM, Ozawa M, Kikuchi T et al. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, TC1 defining (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 1999; 113: 752-9.
8. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994; 76: 301-14.
9. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996; 272: 60-6.
10. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001; 2: 123-8.
11. Teraki Y, Shiohara T. Preferential expression of alphaEbeta7 integrin (CD103) on CD8+ T cells in the psoriatic epidermis: regulation by interleukins 4 and 12 and transforming growth factor-beta. Br J Dermatol 2002; 147: 1118-26.
12. Rottman JB, Smith TL, Ganley KG et al. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin αEβ7 in the pathogenesis of psoriasis vulgaris. Lab Invest 2001; 81: 335-47.
13. Davison SC, Ballsdon A, Allen MH et al. Early migration of cutaneous lymphocyte-associated antigen (CLA) positive T cells into evolving psoriatic plaques. Exp Dermatol 2001; 10: 280-5.
14. Onuma S. Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis. J Dermatol 1994; 21: 223-32.
15. Wakita H, Takigawa M. E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques. Arch Dermatol 1994; 130: 457-63.
16. Sigmundsdottir H, Gudjonsson JE, Jonsdottir I et al. The frequency of CLA+CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease. Clin Exp Immunol 2001; 126: 365-9.
17. Bonecchi R, Blanchi G, Bordignon PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187: 129-34.
18. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187: 875-83.
19. Vestergaard C, Bang K, Gesser B et al. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 2000; 115: 640-6.
20. Nakatani T, Kaburagi Y, Shimada Y et al. CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis. J Allergy Clin Immunol 2001; 107: 353-8.
21. Wakugawa M, Nakamura K, Kakinuma T et al. CC chemokine receptor 4 expression on peripheral blood CD4+ T cells reflects disease activity of atopic dermatitis. J Invest Dermatol 2001; 117: 188-96.
22. Vestergaard C, Deleuran B, Cesser B, Gronhojlarsen C. Expression of the T-helper 2-specific chemokine receptor CCR4 on CCR10-positive lymphocytes in atopic dermatitis skin but not in psoriasis skin. Br J Dermatol 2003; 149: 457-63.
23. Campbell JJ, Haraldsen G, Pan J, Rottman J et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999; 400: 776-80.
24. Andrew DP, Ruffing N, Kim CH et al. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J Immunol 2001; 166: 103-11.
25. Kim CH, Rott L, Kunkel EJ et al. Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001; 108: 1331-9.
26. Homey B, Dieu-Nosjean MC, Wiesenborn A et al. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 2000; 164: 6621-32.
27. Sallusto F, Lenig D, Förster R et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-12.
28. Campbell JJ, Murphy KE, Kunkel EJ et al. CCR7 expression and memory T cell diversity in humans. J Immunol 2001; 166: 877-84.
29. Unsoeld H, Krautwald S, Voehringer D et al. Cutting edge: CCR7+ and CCR7- memory T cells do not differ in immediate effector cell function. J Immunol 2002; 169: 638-41.